InvestorsHub Logo
Followers 50
Posts 8837
Boards Moderated 0
Alias Born 12/19/2019

Re: None

Wednesday, 04/19/2023 5:23:53 PM

Wednesday, April 19, 2023 5:23:53 PM

Post# of 13041
On the books we have a lot of debt but per ceo our revs are gonna surpass that .. been delays and taking longer than expected as to why we haven’t had updates and a roadmap . 30k left in convertible debt this is “ friendly” and an old legacy holder was liquidating last month or so and that’s what held us back . Small rs if anything late this year , no further capital raise needed per ceo and pr machine and ir relations are cranking up . Big pharma and government causing pharmacy license transfer delays- our main issue